November 9, 2020

The Growing Opportunities and Limitations in Today’s Data Analytics

by Paul Adams
PM360 logo

With more data and advancements in how to analyze it, marketers are entering a world filled with possibilities. EVP Justin Chase shares how developments in Auto Content Recognition (ACR) can be useful to pharma marketers.

Related Posts

11|09|20

Inside EVERSANA INTOUCH’s AI-Focused Ad Campaign

With more data and advancements in how to analyze it, marketers are entering a world filled with possibilities. EVP Justin Chase shares how developments in Auto Content Recognition (ACR) can be useful to pharma marketers.

View Blog Post

11|09|20

Can a Celebrity Influencer Work for Your Brand?

With more data and advancements in how to analyze it, marketers are entering a world filled with possibilities. EVP Justin Chase shares how developments in Auto Content Recognition (ACR) can be useful to pharma marketers.

View Blog Post

11|09|20

OpenAI’s New o1 Series Models’ Focus on “Reasoning” and What It Could Mean to Lifesciences Brands and Marketers

With more data and advancements in how to analyze it, marketers are entering a world filled with possibilities. EVP Justin Chase shares how developments in Auto Content Recognition (ACR) can be useful to pharma marketers.

View Blog Post